Epidemiological Features and the Incidence Trend of Brain Cancers in Iran (2004–2008)

Fatemeh Sadat Asgarian, Alireza Moraveji, Mehrdad Mahdian, Hossein Akbari


Background: The objective of this research is to consider the incidence of brain cancers in Iran during the years 2004–2008 to improve reporting, distribution of the disease.

Methods: In this cross‑section study, the study population was all brain cancer cases diagnosed in Iran between 2004 and 2008. Age‑standardized rate (ASR) per 100,000 persons and crude rate were calculated using direct standardization. Data were analyzed using Statistical Package for the Social Sciences (SPSS version 16) and Microsoft Office Excel 2010.

Results: During the period 2004–2008, the ASR and crude rate of brain cancers among males were 2.37, 2.46, 2.77, 2.84, 4.16 and 2.13, 2.11, 2.40, 2.49, 3.61, respectively, and among females the ASR and crude rates were (1.64, 1.67, 2.04, 2.17, 3.09) and (1.45, 1.45, 1.76, 1.84, 2.62), respectively.

Conclusions: According to the study results, a significant increase in the incidence of brain cancer was observed over a 4‑year period in Iran. Hence, screening and early detection programs for this type of cancer are highly recommended.


Brain; cancer; epidemiology; incidence; Iran

Full Text:



Asgarian F, Mirzaei M, Asgarian S, Jazayeri M. Epidemiology of

breast cancer and the age distribution of patients over a period of

ten years. Iran Quar J Breast Dis 2016;9:31‑6.

Amori N, Aghajani M, Asgarian F, Jazayeri M. Epidemiology

and trend of common cancers in Iran (2004–2008). Eur J Cancer

Care 2017;26:e12449.

Mousavi SM, Gouya MM, Ramazani R, Davanlou M,

Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in

Iran. Ann Oncol 2009;20:556‑63.

Cabanes A, Vidal E, Aragonés N, Pérez‑Gómez B, Pollán M,

Lope V, et al. Cancer mortality trends in Spain: 1980–2007. Ann

Oncol 2010;21(suppl_3):iii14‑20.

Mehrabani D, Tabei S, Heydari S, Shamsina S, Shokrpour N,

Amini M, et al. Cancer occurrence in Fars province, southern

Iran. Iran Red Crescent Med J 2008;10:314‑22.

Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E,

Grüber A, et al. Epidemiology of meningiomas. Neurochirurgie


Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain

cancer incidence and survival in the United States: Surveillance,

Epidemiology, and End Results Program, 1973 to 2001.

Neurosurg Focus 2006;20:E1.

Wrensch M, Minn Y, Chew T, Bondy M, Berger MS.

Epidemiology of primary brain tumors: Current concepts and

review of the literature. Neuro Oncol 2002;4:278‑99.

Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer

incidence in five continents Volume VIII. IARC scientific

publication. 2002.

Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS,

Davis FG, Il’Yasova D, et al. Brain tumor epidemiology:

Consensus from the brain tumor epidemiology consortium.

Cancer 2008;113:1953‑68.

Jazayeri SB, Shokraneh F, Ramezani R, Alimi M, Saadat S,

Rahimi-Movaghar V. Epidemiology of primary brain and spinal

cord tumors in Iran: a systematic review. The Neuroscience

Journal of Shefaye Khatam. 2013;1:13-20.

Salimi A, Zali A, Seddighi AS, Seddighi A, Meshkat S,

Hosseini M, et al. Descriptive epidemiology of brain and central

nervous system tumours: Results from iran national cancer

registry, 2010‑2014. Jf Cancer Epidemiol 2020;2020:3534641.

Gupta T, Achari R, Chatterjee A, Chen Z‑P, Mehta M,

Bouffet E, et al. Comparison of epidemiology and outcomes in

neuro‑oncology between the East and the West: Challenges and

opportunities. Clin Oncol 2019;31:539‑48.

Asgarian FS, Mahdian M, Amori N. Epidemiology and trends of

gastrointestinal cancer in Iran (2004–2008). J Cancer Res Ther


Bray F, Ferlay J, Laversanne M, Brewster DH,

Gombe Mbalawa C, Kohler B, et al. Cancer I ncidence in Five

C ontinents: inclusion criteria, highlights from Volume X and

the global status of cancer registration. International journal of

cancer. 2015;137:2060-71.

Goya M. Iranian Annual Cancer Registration Report 2005/2006.

Ministry of Health and Medical Education, Health Deputy.

Center for Disease Control and Prevention. 2007.

Bab S, Abdifard E, Elyasianfar S, Mohammadi P, Mohammadi E,

Izadi N, et al. Trend of the incidence of brain cancer in Iran and

it’s 6 geographical regions during 2000‑2005. Pharmacophore


Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA,

Jemal A. Global cancer statistics 2018: GLOBOCAN estimates

of incidence and mortality worldwide for 36 cancers in 185

countries. CA Cancer J Clin 2018;68:394‑424.

Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T,

Alizadeh‑Navaei R, Allen C, et al. Global, regional, and national

cancer incidence, mortality, years of life lost, years lived with

disability, and disability‑adjusted life‑years for 29 cancer groups,

to 2016: A systematic analysis for the global burden of

disease study. JAMA Oncol 2018;4:1553‑68.

Zendehdel K. Cancer statistics in IR Iran in 2018. Basic Clin

Cancer Res 2019;11:1‑4.

Cowppli‑Bony A, Bouvier G, Rué M, Loiseau H, Vital A,

Lebailly P, et al. Brain tumors and hormonal factors: Review

of the epidemiological literature. Cancer Causes Control